Deep Track Capital, LP
CIK 1856083 · View on SEC EDGAR ↗
- Portfolio value
- $6.9B
- Positions
- 67
- As of
- June 30, 2026
#651 of 9,443 by 13F value · top 6.9%
Portfolio value QoQ: +12.2% 13F does not disclose cash
- Top 10 holdings weight
- 39.61%
- Top 25 holdings weight
- 73.96%
- Positions above 1%
- 33
- Effective number of positions
- 35.8
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 27.67% Est. buys $1,797,974,228 · sells $2,345,166,731
Median holding: 3.0 quarters Tracked Q4 2024–Q2 2026 · 47.5% still held
- New positions
- 19
- Increased
- 22
- Decreased
- 15
- Closed
- 15
On this page
- Performance vs S&P How this manager's 13F portfolio performed against the S&P 500.
- Sector breakdown How the portfolio splits across market sectors.
- Portfolio Every stock this institution reports holding, from its latest 13F.
- High-conviction bets The holdings this manager is most concentrated in.
- Biggest new bets Brand-new positions opened in the latest quarter.
- Top moves The biggest position increases and decreases this quarter.
- Exited positions Positions the manager fully sold out of last quarter.
- Related The person behind this filer, where we can match one.
Performance vs S&P 500
Annualized: +67.9% · S&P 500: +18.0%
Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.
Priceable coverage: 93.2% · Options excluded: 10.4%
Sector breakdown
Healthcare
95.4%
Other/Unmapped
4.6%
Full portfolio 67 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| GH Guardant Health, Inc. - Common Stock | $509,098,599 | 7.41% | 3,393,312 | $200,745,278 | Up ×2 | ||
| IMVT Immunovant, Inc. - Common Stock | $359,914,548 | 5.24% | 9,341,151 | $73,584,588 | Down ×1 | ||
| GPCR Structure Therapeutics Inc. - American Depositary Shares | $254,399,664 | 3.70% | 4,740,072 | $48,110,990 | Up ×2 | ||
| PCVX Vaxcyte, Inc. - Common Stock | $249,959,000 | 3.64% | 4,300,000 | $86,000 | |||
| ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | $248,349,750 | 3.61% | 825,000 | Up ×1 | |||
| MANE Veradermics, Incorporated Common Stock | $245,880,000 | 3.58% | 2,000,000 | $214,305,000 | Up ×1 | ||
| TARS Tarsus Pharmaceuticals, Inc. - Common Stock | $230,786,378 | 3.36% | 3,666,768 | $-21,753,622 | Up ×5 | ||
| NUVL Nuvalent, Inc. - Class A Common Stock | $220,240,267 | 3.21% | 1,783,322 | $79,235,873 | Up ×1 | ||
| ALKS Alkermes plc - Ordinary Shares | $209,580,000 | 3.05% | 4,000,000 | $82,626,179 | Up ×2 | ||
| OCUL Ocular Therapeutix, Inc. - Common Stock | $193,319,289 | 2.81% | 19,686,282 | $26,576,480 | |||
| BMRN BioMarin Pharmaceutical Inc. - Common Stock | $189,254,063 | 2.75% | 3,307,481 | $124,290,563 | Up ×1 | ||
| NRIX Nurix Therapeutics, Inc. - Common stock | $187,686,398 | 2.73% | 7,736,455 | $89,335,116 | Up ×1 | ||
| ORKA Oruka Therapeutics, Inc. - Common Stock | $183,297,420 | 2.67% | 1,926,000 | $83,519,763 | Down ×3 | ||
| ALMS Alumis Inc. - Common Stock | $178,648,422 | 2.60% | 6,348,558 | $29,448,154 | Down ×1 | ||
| IONS Ionis Pharmaceuticals, Inc. - Common Stock | $174,438,000 | 2.54% | 2,200,000 | $28,012,500 | Up ×2 | ||
| CMPS COMPASS Pathways Plc - American Depository Shares | $172,085,168 | 2.50% | 12,161,496 | $104,832,095 | |||
| VERA Vera Therapeutics, Inc. - Class A Common Stock | $171,640,000 | 2.50% | 4,000,000 | $6,452,925 | Down ×1 | ||
| AXSM Axsome Therapeutics, Inc. - Common Stock | $171,339,000 | 2.49% | 700,000 | $-14,583,000 | Down ×2 | ||
| GMAB Genmab A/S - American Depositary Shares | $155,205,500 | 2.26% | 5,650,000 | $56,920,502 | Up ×1 | ||
| MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares | $136,271,017 | 1.98% | 6,999,025 | $16,809,811 | Up ×2 | ||
| Unknown issuer (CUSIP: 423494103) | $132,304,876 | 1.93% | 3,602,093 | Up ×1 | |||
| TNGX Tango Therapeutics, Inc. - Common Stock | $131,292,000 | 1.91% | 4,200,000 | $73,762,000 | Up ×3 | ||
| DFTX Definium Therapeutics, Inc. - Common Shares | $129,360,000 | 1.88% | 2,750,000 | $72,660,000 | Down ×1 | ||
| GRAL GRAIL, Inc. - Common Stock | $125,271,627 | 1.82% | 1,834,944 | $36,237,478 | Up ×2 | ||
| BCAX Bicara Therapeutics Inc. - Common Stock | $121,729,000 | 1.77% | 4,100,000 | $40,925,875 | Up ×3 | ||
| MAZE Maze Therapeutics, Inc. - Common Stock | $111,379,859 | 1.62% | 3,732,569 | $7,574,633 | Up ×1 | ||
| CLDX Celldex Therapeutics, Inc. - Common Stock | $109,365,809 | 1.59% | 2,939,151 | $68,637,995 | Up ×1 | ||
| LBRX LB Pharmaceuticals Inc - Common Stock | $108,815,254 | 1.58% | 3,352,804 | $26,135,107 | |||
| MBX MBX Biosciences, Inc. - Common Stock | $95,637,809 | 1.39% | 1,732,569 | $13,324,374 | Down ×2 | ||
| GHRS GH Research PLC - Ordinary Shares | $89,600,018 | 1.30% | 3,333,334 | ||||
| GMAB Genmab A/S - American Depositary Shares | $82,410,000 | 1.20% | 3,000,000 | Call option | Up ×1 | ||
| COGT Cogent Biosciences, Inc. - Common Stock | $77,400,000 | 1.13% | 2,000,000 | $38,910,000 | Up ×2 | ||
| ATAI AtaiBeckley Inc. - Common Stock | $75,979,919 | 1.11% | 14,417,442 | $33,499,919 | Up ×1 | ||
| UTHR United Therapeutics Corporation - Common Stock | $66,978,857 | 0.97% | 123,616 | Up ×1 | |||
| AVTX Avalo Therapeutics, Inc. - Common Stock | $66,712,800 | 0.97% | 3,610,000 | ||||
| VRDN Viridian Therapeutics, Inc. - Common Stock | $65,998,634 | 0.96% | 3,592,740 | $38,733,089 | Up ×1 | ||
| CYTK Cytokinetics, Incorporated - Common Stock | $59,633,000 | 0.87% | 700,000 | $-30,948,431 | Down ×3 | ||
| ALT Altimmune, Inc. - Common Stock | $58,520,000 | 0.85% | 19,250,000 | Up ×1 | |||
| PSNL Personalis, Inc. - Common Stock | $53,600,000 | 0.78% | 4,000,000 | $34,490,000 | Up ×1 | ||
| ACRS Aclaris Therapeutics, Inc. - Common Stock | $49,435,050 | 0.72% | 9,345,000 | $14,391,300 | |||
| CRMD CorMedix Inc. - Common Stock | $49,251,497 | 0.72% | 6,274,076 | $6,650,521 | |||
| WGS GeneDx Holdings Corp. - Class A Common Stock | $48,055,000 | 0.70% | 700,000 | Up ×1 | |||
| HROW Harrow, Inc. - Common Stock | $41,153,430 | 0.60% | 969,000 | Up ×1 | |||
| CRVS Corvus Pharmaceuticals, Inc. - Common Stock | $37,229,569 | 0.54% | 2,491,939 | $778,353 | Up ×1 | ||
| SLDB Solid Biosciences Inc. - Common Stock | $35,614,969 | 0.52% | 3,565,062 | $9,946,523 | |||
| BEAM Beam Therapeutics Inc. - Common Stock | $34,320,000 | 0.50% | 1,000,000 | $14,761,170 | Up ×1 | ||
| DYN Dyne Therapeutics, Inc. - Common Stock | $33,315,000 | 0.48% | 1,500,000 | $-2,945,000 | Down ×2 | ||
| IMMX Immix Biopharma, Inc. - Common Stock | $28,610,250 | 0.42% | 2,775,000 | Up ×1 | |||
| XFOR X4 Pharmaceuticals, Inc. - Common Stock | $27,453,795 | 0.40% | 5,878,757 | $1,271,515 | Down ×1 | ||
| STTK Shattuck Labs, Inc. - Common Stock | $25,724,734 | 0.37% | 3,706,734 | Up ×1 | |||
| MNKD MannKind Corporation - Common Stock | $25,560,000 | 0.37% | 6,000,000 | Up ×1 | |||
| IPSC Century Therapeutics, Inc. - Common Stock | $23,183,480 | 0.34% | 9,462,645 | $1,741,176 | Down ×1 | ||
| Unknown issuer (CUSIP: 370920100) | $22,501,459 | 0.33% | 1,333,815 | Up ×1 | |||
| VSTM Verastem, Inc. - Common Stock | $21,930,047 | 0.32% | 5,740,850 | $-8,496,458 | |||
| KURA Kura Oncology, Inc. - Common Stock | $21,704,858 | 0.32% | 1,978,565 | $212,862 | Down ×1 | ||
| ENTA Enanta Pharmaceuticals, Inc. - Common Stock | $21,055,955 | 0.31% | 1,444,167 | $-3,659,275 | Down ×1 | ||
| NKTR Nektar Therapeutics - Common Stock | $20,943,000 | 0.30% | 300,000 | Up ×1 | |||
| OLMA Olema Pharmaceuticals, Inc. - Common Stock | $18,765,000 | 0.27% | 1,500,000 | ||||
| Unknown issuer (CUSIP: 482931102) | $15,421,000 | 0.22% | 700,000 | Up ×1 | |||
| Unknown issuer (CUSIP: 485925101) | $14,310,000 | 0.21% | 600,000 | Up ×1 | |||
| ELVN Enliven Therapeutics, Inc. - Common Stock | $11,418,750 | 0.17% | 225,000 | Up ×1 | |||
| PMN ProMIS Neurosciences Inc. - Common Shares | $10,997,220 | 0.16% | 835,655 | $384,401 | |||
| IMCR Immunocore Holdings plc - American Depositary Shares | $9,881,172 | 0.14% | 311,218 | $-48,365,131 | Down ×2 | ||
| XNCR Xencor, Inc. - Common Stock | $9,556,171 | 0.14% | 593,551 | ||||
| CNTX Context Therapeutics Inc. - Common Stock | $4,109,581 | 0.06% | 7,419,355 | $-15,329,129 | |||
| IVA Inventiva S.A. - American Depository Shares | $3,024,000 | 0.04% | 800,000 | $-3,760,614 | Down ×1 | ||
| ALGS Aligos Therapeutics, Inc. - Common stock | $2,562,515 | 0.04% | 444,110 | $-737,222 | |||
| No matches | |||||||
Conviction holdings
Positions increased for 3+ consecutive quarters.
Share counts are as reported in 13F filings (not split-adjusted)
Biggest new bets
New positions opened this quarter, largest first.
| Security | Value | Shares | % of portfolio |
|---|---|---|---|
| ALNY | $248,349,750 | 825,000 | 3.61% |
| Unknown issuer (CUSIP: 423494103) | $132,304,876 | 3,602,093 | 1.93% |
| GHRS | $89,600,018 | 3,333,334 | 1.30% |
| GMAB | $82,410,000 | 3,000,000 | 1.20% |
| UTHR | $66,978,857 | 123,616 | 0.97% |
| AVTX | $66,712,800 | 3,610,000 | 0.97% |
| ALT | $58,520,000 | 19,250,000 | 0.85% |
| WGS | $48,055,000 | 700,000 | 0.70% |
| HROW | $41,153,430 | 969,000 | 0.60% |
| IMMX | $28,610,250 | 2,775,000 | 0.42% |
| STTK | $25,724,734 | 3,706,734 | 0.37% |
| MNKD | $25,560,000 | 6,000,000 | 0.37% |
| Unknown issuer (CUSIP: 370920100) | $22,501,459 | 1,333,815 | 0.33% |
| NKTR | $20,943,000 | 300,000 | 0.30% |
| OLMA | $18,765,000 | 1,500,000 | 0.27% |
Top movers (QoQ)
| Security | Action | Shares Δ | Value Δ |
|---|---|---|---|
| GH | Bought more | +55K | +$200.7M |
| BMRN | Bought more | +2.2M | +$124.3M |
| CMPS | Price move only | +0 | +$104.8M |
| NRIX | Bought more | +1.4M | +$89.3M |
| ORKA | Trimmed | -108K | +$83.5M |
| ALKS | Bought more | +410K | +$82.6M |
| NUVL | Bought more | +407K | +$79.2M |
| TNGX | Bought more | +1.4M | +$73.8M |
| IMVT | Trimmed | -2.2M | +$73.6M |
| DFTX | Trimmed | -250K | +$72.7M |
1 position hidden (data completeness check)
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.
| Security | Quarter | Shares before | Value before | Price since exit |
|---|---|---|---|---|
| XBI | June 30, 2026 | 10,000,000 | $1,277,300,000 | No longer tracked |
| ITCI | June 30, 2025 | 2,000,000 | $263,840,000 | No longer tracked |
| DVAX | March 31, 2026 | 15,726,349 | $241,871,248 | No longer tracked |
| AKRO | Dec. 31, 2025 | 4,000,978 | $189,966,435 | No longer tracked |
| APLS | June 30, 2026 | 4,532,374 | $182,337,406 | No longer tracked |
| INSM | Sept. 30, 2025 | 1,750,000 | $176,120,000 | -10.9% |
| ETNB | Dec. 31, 2025 | 9,356,171 | $137,535,714 | No longer tracked |
| CNTA | June 30, 2026 | 3,158,041 | $125,437,389 | No longer tracked |
| SWTX | March 31, 2025 | 3,460,756 | $125,037,114 | No longer tracked |
| PTGX | Dec. 31, 2025 | 1,715,691 | $113,973,353 | 74.5% |
| BBIO | June 30, 2026 | 841,445 | $62,485,706 | 11.8% |
| TERN | June 30, 2026 | 1,073,877 | $56,614,795 | No longer tracked |
| NMRA | March 31, 2025 | 5,189,800 | $55,011,880 | 59.0% |
| EXAS | Dec. 31, 2025 | 1,000,000 | $54,710,000 | No longer tracked |
| HRMY | March 31, 2025 | 1,450,000 | $49,894,500 | 18.9% |
| RARE | Sept. 30, 2025 | 1,350,000 | $49,086,000 | -11.7% |
| GERN | June 30, 2026 | 31,720,278 | $47,263,214 | 22.3% |
| ANIP | June 30, 2026 | 600,000 | $46,140,000 | -5.8% |
| GMAB | March 31, 2025 | 2,000,000 | $41,740,000 | 71.3% |
| DNTH | Sept. 30, 2025 | 2,233,148 | $41,603,547 | 182.1% |
| VRNA | March 31, 2025 | 850,000 | $39,474,000 | No longer tracked |
| SLNO | June 30, 2026 | 1,078,710 | $36,115,211 | No longer tracked |
| AMGN | June 30, 2025 | 113,035 | $35,216,054 | 56.2% |
| OLMA | Dec. 31, 2025 | 3,470,172 | $33,972,984 | -56.2% |
| MTSR | Sept. 30, 2025 | 1,094,408 | $31,135,908 | No longer tracked |
| EWTX | June 30, 2025 | 1,400,000 | $30,800,000 | 242.1% |
| ENGN | June 30, 2026 | 4,377,572 | $29,811,265 | 4.3% |
| CDTX | Dec. 31, 2025 | 300,000 | $28,728,000 | No longer tracked |
| QURE | Dec. 31, 2025 | 483,092 | $28,198,080 | 100.2% |
| TECX | Sept. 30, 2025 | 1,401,938 | $27,856,508 | 130.5% |
| ABVX | Sept. 30, 2025 | 3,480,144 | $26,623,102 | 38.6% |
| APGE | June 30, 2026 | 285,000 | $23,988,450 | 1.5% |
| CNTA | March 31, 2025 | 1,350,000 | $22,612,500 | No longer tracked |
| MNMD | March 31, 2026 | 1,676,540 | $22,448,871 | No longer tracked |
| DYN | June 30, 2025 | 2,000,000 | $20,920,000 | 173.3% |
| JBIO | Dec. 31, 2025 | 2,279,892 | $19,675,468 | 40.4% |
| GLPG | June 30, 2025 | 741,068 | $18,615,628 | No longer tracked |
| GHRS | Dec. 31, 2025 | 1,250,000 | $17,875,000 | 131.3% |
| JANX | June 30, 2026 | 1,187,290 | $16,503,331 | 13.2% |
| XENE | March 31, 2026 | 366,435 | $16,423,617 | 6.0% |
| SAGE | June 30, 2025 | 2,038,845 | $16,208,818 | No longer tracked |
| UPB | Sept. 30, 2025 | 1,442,767 | $15,841,582 | -61.2% |
| GMAB | Dec. 31, 2025 | 481,267 | $14,760,459 | 8.9% |
| MRUS | Sept. 30, 2025 | 275,000 | $14,465,000 | No longer tracked |
| SRPT | Sept. 30, 2025 | 709,800 | $12,137,580 | -0.6% |
| BCYC | Sept. 30, 2025 | 1,203,244 | $8,362,546 | -47.6% |
| CBIO | June 30, 2026 | 453,686 | $8,334,212 | -6.4% |
| IMA | Dec. 31, 2025 | 878,516 | $7,159,905 | -18.1% |
| LRMR | June 30, 2026 | 1,500,000 | $6,750,000 | 35.0% |
| CNTA | Sept. 30, 2025 | 500,000 | $6,570,000 | No longer tracked |
| XNCR | Dec. 31, 2025 | 549,439 | $6,444,919 | 75.0% |
| HELP | June 30, 2026 | 1,313,137 | $6,303,058 | 85.0% |
| NVAX | Sept. 30, 2025 | 998,542 | $6,290,815 | -3.6% |
| MNPR | March 31, 2026 | 95,408 | $6,230,142 | 118.5% |
| BEAM | June 30, 2025 | 315,765 | $6,166,890 | 62.0% |
| IVVD | Sept. 30, 2025 | 8,585,980 | $6,138,976 | -10.5% |
| RGLS | June 30, 2025 | 3,262,564 | $5,709,487 | No longer tracked |
| BHVN | March 31, 2026 | 500,000 | $5,645,000 | 64.4% |
| PEPG | Dec. 31, 2025 | 1,200,000 | $5,544,000 | -52.1% |
| PLRX | Sept. 30, 2025 | 3,947,807 | $4,579,456 | -20.9% |
| AUTL | Dec. 31, 2025 | 2,568,613 | $4,186,839 | 24.1% |
| INO | Sept. 30, 2025 | 1,981,370 | $4,032,088 | -46.2% |
| BLLN | June 30, 2026 | 50,000 | $3,947,000 | -22.3% |
| RAPT | March 31, 2026 | 110,448 | $3,740,874 | No longer tracked |
| KRRO | Sept. 30, 2025 | 277,966 | $3,471,795 | -71.8% |
| FDMT | March 31, 2025 | 609,900 | $3,397,143 | 386.2% |
| IKNA | Sept. 30, 2025 | 2,515,513 | $3,370,787 | No longer tracked |
| SYRE | Sept. 30, 2025 | 219,015 | $3,278,655 | 532.2% |
| ACAD | Dec. 31, 2025 | 105,085 | $2,242,514 | 11.5% |
| AVTX | Dec. 31, 2025 | 144,600 | $1,837,866 | 11.6% |
| NKTR | March 31, 2025 | 1,975,998 | $1,837,678 | 633.4% |
| ALLK | June 30, 2025 | 7,232,701 | $1,646,163 | No longer tracked |
| NGNE | June 30, 2025 | 116,660 | $1,366,089 | 150.9% |
| SEPN | Sept. 30, 2025 | 121,716 | $1,286,538 | 129.9% |
| SAVA | March 31, 2025 | 500,000 | $1,180,000 | No longer tracked |
| ZURA | Dec. 31, 2025 | 259,014 | $1,121,531 | 9.2% |
| RAPP | Sept. 30, 2025 | 98,237 | $1,116,955 | 63.7% |
| CLYM | Dec. 31, 2025 | 509,789 | $1,024,676 | 328.3% |
| OKUR | Sept. 30, 2025 | 180,510 | $431,419 | 44.7% |
| ANL | March 31, 2026 | 34,852 | $49,490 | 102.6% |